Sumitomo Mitsui DS Asset Management Company Ltd increased its position in Varian Medical Systems, Inc. (NYSE:VAR) by 21.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 6,155 shares of the medical equipment provider’s stock after purchasing an additional 1,075 shares during the quarter. Sumitomo Mitsui DS Asset Management Company Ltd’s holdings in Varian Medical Systems were worth $874,000 as of its most recent SEC filing.

A number of other hedge funds have also recently made changes to their positions in the stock. BlackRock Inc. boosted its holdings in Varian Medical Systems by 4.0% during the second quarter. BlackRock Inc. now owns 8,316,444 shares of the medical equipment provider’s stock worth $1,132,117,000 after buying an additional 319,325 shares during the last quarter. Disciplined Growth Investors Inc. MN boosted its holdings in Varian Medical Systems by 2.2% during the third quarter. Disciplined Growth Investors Inc. MN now owns 727,055 shares of the medical equipment provider’s stock worth $86,585,000 after buying an additional 15,365 shares during the last quarter. Boston Trust Walden Corp boosted its holdings in Varian Medical Systems by 2.9% during the fourth quarter. Boston Trust Walden Corp now owns 468,371 shares of the medical equipment provider’s stock worth $66,513,000 after buying an additional 13,029 shares during the last quarter. Russell Investments Group Ltd. boosted its holdings in Varian Medical Systems by 0.4% during the third quarter. Russell Investments Group Ltd. now owns 440,251 shares of the medical equipment provider’s stock worth $52,187,000 after buying an additional 1,748 shares during the last quarter. Finally, Nuveen Asset Management LLC boosted its holdings in Varian Medical Systems by 14,499.7% during the second quarter. Nuveen Asset Management LLC now owns 378,862 shares of the medical equipment provider’s stock worth $51,574,000 after buying an additional 376,267 shares during the last quarter. Hedge funds and other institutional investors own 89.13% of the company’s stock.

In other news, SVP John W. Kuo sold 465 shares of Varian Medical Systems stock in a transaction dated Friday, November 15th. The stock was sold at an average price of $128.02, for a total transaction of $59,529.30. Following the transaction, the senior vice president now owns 35,568 shares in the company, valued at approximately $4,553,415.36. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Christopher A. Toth sold 564 shares of Varian Medical Systems stock in a transaction dated Friday, December 6th. The shares were sold at an average price of $138.95, for a total value of $78,367.80. Following the transaction, the senior vice president now owns 1,830 shares in the company, valued at approximately $254,278.50. The disclosure for this sale can be found here. Insiders have sold a total of 18,200 shares of company stock worth $2,525,045 in the last quarter. 0.62% of the stock is currently owned by company insiders.

Shares of VAR opened at $145.55 on Tuesday. Varian Medical Systems, Inc. has a 1 year low of $103.92 and a 1 year high of $150.06. The stock has a market cap of $13.48 billion, a P/E ratio of 43.19, a price-to-earnings-growth ratio of 3.44 and a beta of 0.89. The stock’s 50-day moving average price is $144.63 and its two-hundred day moving average price is $125.97.

A number of brokerages have issued reports on VAR. Robert W. Baird restated a “buy” rating and set a $158.00 target price on shares of Varian Medical Systems in a report on Monday, November 18th. Evercore ISI upgraded Varian Medical Systems from an “in-line” rating to an “outperform” rating and raised their target price for the stock from $130.00 to $164.00 in a report on Thursday, January 2nd. UBS Group raised their target price on Varian Medical Systems from $155.00 to $160.00 and gave the stock a “buy” rating in a report on Wednesday, December 4th. Barrington Research raised their target price on Varian Medical Systems from $146.00 to $152.00 and gave the stock an “outperform” rating in a report on Thursday, October 24th. Finally, BTIG Research restated a “buy” rating and set a $157.00 target price on shares of Varian Medical Systems in a report on Friday. Two research analysts have rated the stock with a hold rating and six have given a buy rating to the company. The company presently has a consensus rating of “Buy” and an average price target of $158.86.

Varian Medical Systems Company Profile

Varian Medical Systems, Inc designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates through two segments, Oncology Systems and Proton Solutions. The Oncology Systems segment offers hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy, as well as related quality assurance equipment.

Featured Story: How can investors find ex-dividend dates?

Institutional Ownership by Quarter for Varian Medical Systems (NYSE:VAR)

Receive News & Ratings for Varian Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.